Cervical Stimulation for Tinnitus and Hearing Health

A pilot study in 2024 found that a personalized approach to neck nerve stimulation is essential for reliably increasing the body’s relaxation response. The research, led by Shubham Debnath and colleagues at Northwell Health’s Feinstein Institutes, demonstrates that transcutaneous cervical electrical stimulation (TCES) can modulate the autonomic nervous system, but the optimal settings vary significantly from person to person.

How Researchers Measured the Body’s Response

The study involved 20 healthy adults who completed four separate testing sessions. The goal was to systematically test different TCES parameters to see which best increased parasympathetic nervous system activity—the branch responsible for rest and relaxation.

Researchers used two primary biomarkers: heart rate variability (specifically RMSSD, a measure of cardiac vagal tone) and global EEG alpha-band power, which is associated with a relaxed, wakeful cortical state. They collected a suite of autonomic data, including electrocardiography, blood pressure, pupillometry, and photoplethysmography.

Across the sessions, they varied four key parameters:

• Frequency: 10, 25, 40, and 150 Hz.
• Current Intensity: Below sensation, at sensation threshold, and above sensation threshold.
• Electrode Montage: Placed on both sides of the neck, only the left, or only the right.
• Duration: 4 minutes versus 20 minutes.

Importantly, the study used a sequential optimization design. The frequency that worked best for an individual in the first visit was then used as the basis for testing intensity and placement in subsequent visits, mimicking a personalized treatment protocol. You can read the full methodology in the source paper: Bioelectron Med. 2026;12(1):16. PMID: 42402630.

The Critical Findings: Personalization is Non-Negotiable

The results clearly argue against a one-size-fits-all stimulation protocol.

Frequency is Deeply Individual

The team found no single frequency that produced a significantly higher response across the group. Instead, each participant had a personalized preferred frequency. On average, this individual frequency increased their RMSSD—a key measure of parasympathetic activity—by 41% in the first session. This underscores that effective neuromodulation, much like effective management for conditions like tinnitus or misophonia, must account for individual neurophysiological differences.

Stronger Sensation and Side Placement Matter

When testing current intensity using each person’s preferred frequency, the “supra-sensation threshold” (a feeling stronger than the initial tingling) was most effective. Sixty percent of participants had their strongest autonomic response at this level.

The placement of electrodes yielded a surprising and important result. Left-sided stimulation actually decreased both RMSSD and alpha-band power. In contrast, right-sided and bilateral montages produced similar increases in these relaxation biomarkers. This lateralized effect has significant implications for clinical application and aligns with known asymmetries in autonomic nervous system control.

Responses Change, Requiring Recalibration

A notable discovery was that the cardiac vagal response decreased in successive sessions. When researchers re-tested for a preferred frequency in the fourth visit—before testing duration—the mean RMSSD response jumped by 54%. However, the preferred frequency had shifted for 75% of the participants. This indicates that the nervous system’s reactivity to stimulation is not static and that treatment parameters may need periodic adjustment.

Duration: Longer Isn’t Necessarily Better

Comparing 4-minute and 20-minute stimulation periods, standard autonomic measures (like blood pressure) did not change more with longer duration. Analysis of pulse rate variability during the 20-minute sessions revealed oscillatory autonomic dynamics, with peak parasympathetic responses frequently emerging around the 4-minute mark. This suggests that shorter stimulation bouts could be as effective as longer ones for eliciting a targeted response.

Implications for Hearing and Sound Disorder Therapies

This research provides a methodological framework for personalizing neuromodulation therapies. For individuals with tinnitus, hyperacusis, or misophonia, where dysregulation of the autonomic nervous system and central auditory processing is common, a calibrated TCES approach could be a valuable tool. The study’s biomarker-guided method—using real-time HRV and EEG data to select parameters—moves beyond guesswork.

The finding that left-sided stimulation was counterproductive is critical for safety and protocol design. It also invites further investigation into how lateralized vagus nerve stimulation interacts with auditory-limbic pathways, a connection explored in our article on integrated auditory health.

Furthermore, the concept of shifting responses and the need for recalibration mirrors findings in other neuromodulatory and behavioral treatments. For instance, the effectiveness of cognitive behavioral therapy can depend on baseline states, a principle noted in research on CBT-I outcomes where baseline depression predicts long-term results. It reinforces that managing chronic conditions often requires adaptable, responsive strategies rather than fixed prescriptions.

A Framework for Future Clinical Application

Debnath and colleagues conclude that a personalized, biomarker-guided approach is essential for future clinical applications of TCES. Their pilot work charts a course for developing precise, adaptive stimulation protocols. The next steps will involve testing this optimization framework in clinical populations, such as those with sound tolerance disorders or chronic tinnitus, where modulating autonomic tone and cortical arousal could provide significant relief.

The study confirms that the path to reliable neuromodulation does not lie in a universal setting, but in a dynamic process of measurement and adjustment tailored to the individual’s current nervous system state.